TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Government & Organizations

    The Long Run with Luke Timmerman

    “The Long Run”

    Antarctic explorer Ernest Shackleton would appreciate today’s biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.

    Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

    Advertise

    Copyright: © All rights reserved

    • Apple Podcasts
    • Google Play
    • Spotify

    Latest Episodes:
    Ep50: Joel Marcus Aug 20, 2019
    Show notes

    Joel Marcus, chairman of Alexandria Real Estate Equities, on building in biotech clusters.


    Ep49: Janelle Anderson Aug 08, 2019
    Show notes

    Janelle Anderson on venture capital and off-the-shelf cell therapy at Century Therapeutics


    Ep48: Cindy Perettie Jul 11, 2019
    Show notes

    Cindy Perettie of Foundation Medicine on genomic analysis for cancer.


    Ep47: Laura Shawver Jul 02, 2019
    Show notes

    Laura Shawver on synthetic biology engineering of cancer drugs.


    Ep46: Liz O'Day Jun 12, 2019
    Show notes

    Liz O'Day on metabolite signatures for predicting cancer drug response.


    Ep45: Jay Bradner May 22, 2019
    Show notes

    Jay Bradner, president of Novartis Institutes for Biomedical Research, on his journey from open biology advocate to pharma leadership.


    Ep44: Sheila Gujrathi May 09, 2019
    Show notes

    Sheila Gujrathi, CEO of Gossamer Bio, immunologic drug developer


    Ep43: Jeff Jonas Apr 24, 2019
    Show notes

    Sage Therapeutics CEO on psychiatric drug development.


    Ep42: Carolyn Bertozzi Apr 09, 2019
    Show notes

    Carolyn Bertozzi on becoming a chemical biologist/glycobiologist.


    Ep41: Bob Langer Mar 27, 2019
    Show notes

    MIT's Bob Langer on his journey in science and entrepreneurship.


    Previous 1 15 16 17 18 19 21 Next

    Related Podcasts

    The Joe Rogan Experience

    1

    The Joe Rogan Experience Comedy
    More Perfect

    2

    More Perfect Government
    Casefile True Crime

    3

    Casefile True Crime Games & Hobbies
    Reply All

    4

    Reply All Games & Hobbies
    You Must Remember This

    5

    You Must Remember This Games & Hobbies
    Real Time with Bill Maher

    6

    Real Time with Bill Maher Games & Hobbies
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights